Levitra Talks
SUBSCRIPTION
  LInks  
Bookmark this Site
 
 Year 2007
   » August 2007
   » July 2007
   » June 2007
   » May 2007
   » Apr 2007
   » Mar 2007
   » Feb 2007
   » Jan 2007
 Year 2006
   » Dec 2006
   » Nov 2006
   » Oct 2006
   » Sept 2006
   » Aug 2006
   » July 2006
   » June 2006
   » May 2006
   » April 2006
   » Mar 2006
   » Feb 2006
   » Jan 2006
 Year 2005
   » Dec 2005
   » Nov 2005
   » Oct 2005
   » Sep 2005
   » Aug 2005
   » July 2005
   » June 2005
   » May 2005
   » Mar 2005
   » Feb 2005
   » Jan 2005
 Year 2004
 Year 2003
 Levitra information
   
Get To Know ED
What is Levitra?
  » FDA Approval
» History & Present Status
Who is Behind Levitra?
Levitra Expectations
Tips for First Timers
Patient Leaflet
Levitra Side Effects
  » Levitra Safety
Levitra Pharmacology
  » Levitra Clinical Data
PDE5 Inhibitors
ED Quiz
Levitra News
   
 
 

  News Home » Dec 2005

Testicular cancer linked to male impotence
Thursday, December 8, 2005

A recent study suggests that confirmed infertile or impotent men may have to consider getting screened for testicular cancer as there is a rise in cases of testicular cancer in infertile men. The study which linked testicular cancer to infertility or impotence, published in the Journal of Urology revealed that infertile men with abnormal semen analyses have 20 - fold greater incidences of testicular cancer compared to the general population.

Testicular cancer is rare and often curable when detected in its early stages. The study further warned that the patients and physicians should be aware of the fact that one of the causes of infertility or impotence could be cancer, particularly testicular cancer. The study also revealed that testicular cancer is the most common type of cancer among men between the age of 15 and 35.

To read more, visit…..
http://www.vanguardngr.com/articles/2002/features/health/gh106122005.html




Disclaimer
| Levitra | Levitra Articles
Levitra ® is a registered trademark of Bayer AG and GlaxoSmithKline PLC.
Copyright © 2005 levitratalks.com, All rights reserved.